|
The company is the latest pharma firm to have either reduced spending in the UK or diverted it to the US.
Category:
News and Media
His resignation marks the latest development in a dispute with parent company Unilever.
Category:
News and Media
Motilal Oswal initiated coverage on NSDL with a 'Neutral' rating, setting a target price of Rs 1,200. While acknowledging NSDL's strong market position and growth potential in India's expanding capital markets, the brokerage suggests the current stock price largely reflects these positives.
Category:
News and Media
All news |
||||||||||||||||||
|